EMJ Respiratory 12 [Supplement 3] . 2024

In this issue

A promotional GSK-sponsored symposium invited three experts to discuss their main considerations when selecting an inhaled corticosteroid (ICS)/inhaled long-acting β2-agonist (LABA) combination for patients with moderate asthma. Ashley Woodcock, Professor of Respiratory Medicine, University of Manchester; and Consultant Physician at The North-West Lung Centre, Wythenshawe Hospital, Manchester, UK, explained why timely assessment is critical for ICS/LABA initiation.